TreeWAS – Variant ID: rs16924016

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N73.6 Female pelvic peritoneal adhesions	0.138	0.862	0.000
N73 Other female pelvic inflammatory diseases	0.106	0.894	0.000
N73.9 Female pelvic inflammatory disease, unspecified	0.094	0.906	0.000
N73.8 Other specified female pelvic inflammatory diseases	0.076	0.924	0.000
N73.5 Female pelvic peritonitis, unspecified	0.076	0.924	0.000
N73.4 Female chronic pelvic peritonitis	0.076	0.924	0.000
N73.3 Female acute pelvic peritonitis	0.076	0.924	0.000
N73.2 Unspecified parametritis and pelvic cellulitis	0.076	0.924	0.000
N73.1 Chronic parametritis and pelvic cellulitis	0.076	0.924	0.000
N73.0 Acute parametritis and pelvic cellulitis	0.076	0.924	0.000
R07.2 Precordial pain	0.000	0.928	0.072
N70-N77 Inflammatory diseases of female pelvic organs	0.048	0.952	0.000
D25.0 Submucous leiomyoma of uterus	0.047	0.953	0.000
N72 Inflammatory disease of cervix uteri	0.046	0.954	0.000
D25.2 Subserosal leiomyoma of uterus	0.045	0.955	0.000
D25 Leiomyoma of uterus	0.041	0.959	0.000
N74 Female pelvic inflammatory disorders in diseases classified elsewhere	0.034	0.966	0.000
N70 Salpingitis and oophoritis	0.032	0.968	0.000
N71 Inflammatory disease of uterus, except cervix	0.030	0.969	0.000
D25.1 Intramural leiomyoma of uterus	0.030	0.970	0.000
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere	0.030	0.970	0.000
N76 Other inflammation of vagina and vulva	0.028	0.972	0.000
N70.1 Chronic salpingitis and oophoritis	0.025	0.975	0.000
N74.8 Female pelvic inflammatory disorders in other diseases classified elsewhere	0.025	0.975	0.000
N74.4 Female chlamydial pelvic inflammatory disease	0.025	0.975	0.000
N74.3 Female gonococcal pelvic inflammatory disease	0.025	0.975	0.000
N74.2 Female syphilitic pelvic inflammatory disease	0.025	0.975	0.000
N74.1 Female tuberculous pelvic inflammatory disease	0.025	0.975	0.000
N74.0 Tuberculous infection of cervix uteri	0.025	0.975	0.000
N70.0 Acute salpingitis and oophoritis	0.023	0.977	0.000
H02.4 Ptosis of eyelid	0.000	0.977	0.023
N76.0 Acute vaginitis	0.022	0.978	0.000
N71.1 Chronic inflammatory disease of uterus	0.022	0.978	0.000
N71.0 Acute inflammatory disease of uterus	0.022	0.978	0.000
N75 Diseases of Bartholin's gland	0.022	0.978	0.000
N77.8 Vulvovaginal ulceration and inflammation in other diseases classified elsewhere	0.022	0.978	0.000
N77.0 Ulceration of vulva in infectious and parasitic diseases classified elsewhere	0.022	0.978	0.000
N76.3 Subacute and chronic vulvitis	0.021	0.979	0.000
N76.6 Ulceration of vulva	0.021	0.979	0.000
N76.5 Ulceration of vagina	0.020	0.979	0.000
N76.1 Subacute and chronic vaginitis	0.020	0.979	0.000
N76.4 Abscess of vulva	0.020	0.980	0.000
N71.9 Inflammatory disease of uterus, unspecified	0.018	0.981	0.000
N76.8 Other specified inflammation of vagina and vulva	0.017	0.982	0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.017	0.982	0.000
N70.9 Salpingitis and oophoritis, unspecified	0.016	0.983	0.000
N75.9 Disease of Bartholin's gland, unspecified	0.016	0.984	0.000
N75.8 Other diseases of Bartholin's gland	0.016	0.984	0.000
N75.0 Cyst of Bartholin's gland	0.014	0.986	0.000
N76.2 Acute vulvitis	0.014	0.986	0.000
N85.8 Other specified noninflammatory disorders of uterus	0.012	0.988	0.000
N97.9 Female infertility, unspecified	0.012	0.988	0.000
N89.8 Other specified noninflammatory disorders of vagina	0.012	0.988	0.000
R07 Pain in throat and chest	0.000	0.988	0.012
N97 Female infertility	0.011	0.989	0.000
D25.9 Leiomyoma of uterus, unspecified	0.010	0.990	0.000
K92.2 Gastro-intestinal haemorrhage, unspecified	0.010	0.990	0.000
N89 Other noninflammatory disorders of vagina	0.010	0.990	0.000
A04.8 Other specified bacterial intestinal infections	0.000	0.990	0.010
N85 Other noninflammatory disorders of uterus, except cervix	0.010	0.990	0.000
N86 Erosion and ectropion of cervix uteri	0.010	0.990	0.000
N80-N98 Noninflammatory disorders of female genital tract	0.010	0.990	0.000
N80.1 Endometriosis of ovary	0.009	0.991	0.000
K92 Other diseases of digestive system	0.009	0.991	0.000
N80 Endometriosis	0.009	0.991	0.000
K92.1 Melaena	0.009	0.991	0.000
N97.1 Female infertility of tubal origin	0.009	0.991	0.000
N88 Other noninflammatory disorders of cervix uteri	0.009	0.991	0.000
N85.0 Endometrial glandular hyperplasia	0.009	0.991	0.000
N80.0 Endometriosis of uterus	0.009	0.991	0.000
N75.1 Abscess of Bartholin's gland	0.008	0.991	0.000
N88.8 Other specified noninflammatory disorders of cervix uteri	0.009	0.991	0.000
R07.3 Other chest pain	0.000	0.991	0.009
N85.1 Endometrial adenomatous hyperplasia	0.009	0.991	0.000
N85.6 Intra-uterine synechiae	0.009	0.991	0.000
N89.9 Noninflammatory disorder of vagina, unspecified	0.008	0.992	0.000
K92.0 Haematemesis	0.008	0.992	0.000
N88.1 Old laceration of cervix uteri	0.008	0.992	0.000
N97.8 Female infertility of other origin	0.008	0.992	0.000
N97.4 Female infertility associated with male factors	0.008	0.992	0.000
N97.3 Female infertility of cervical origin	0.008	0.992	0.000
N97.2 Female infertility of uterine origin	0.008	0.992	0.000
N97.0 Female infertility associated with anovulation	0.008	0.992	0.000
R07.0 Pain in throat	0.000	0.992	0.008
N92 Excessive, frequent and irregular menstruation	0.008	0.992	0.000
N80.8 Other endometriosis	0.008	0.992	0.000
N89.7 Haematocolpos	0.007	0.992	0.000
N89.4 Leukoplakia of vagina	0.007	0.992	0.000
N89.3 Dysplasia of vagina, unspecified	0.007	0.992	0.000
N89.2 Severe vaginal dysplasia, not elsewhere classified	0.007	0.992	0.000
N89.1 Moderate vaginal dysplasia	0.007	0.992	0.000
N89.0 Mild vaginal dysplasia	0.007	0.992	0.000
N85.7 Haematometra	0.007	0.992	0.000
N85.5 Inversion of uterus	0.007	0.992	0.000
N85.3 Subinvolution of uterus	0.007	0.992	0.000
N91 Absent, scanty and rare menstruation	0.007	0.993	0.000
A04.7 Enterocolitis due to Clostridium difficile	0.000	0.993	0.007
N92.4 Excessive bleeding in the premenopausal period	0.007	0.993	0.000
N82 Fistulae involving female genital tract	0.007	0.993	0.000
A04 Other bacterial intestinal infections	0.000	0.993	0.007
N98 Complications associated with artificial fertilisation	0.007	0.993	0.000
N96 Habitual aborter	0.007	0.993	0.000
N89.6 Tight hymenal ring	0.007	0.993	0.000
N80.5 Endometriosis of intestine	0.007	0.993	0.000
N92.6 Irregular menstruation, unspecified	0.007	0.993	0.000
K92.8 Other specified diseases of digestive system	0.007	0.993	0.000
N80.6 Endometriosis in cutaneous scar	0.007	0.993	0.000
N80.4 Endometriosis of rectovaginal septum and vagina	0.007	0.993	0.000
R07.1 Chest pain on breathing	0.000	0.993	0.007
N89.5 Stricture and atresia of vagina	0.007	0.993	0.000
K92.9 Disease of digestive system, unspecified	0.007	0.993	0.000
N88.4 Hypertrophic elongation of cervix uteri	0.007	0.993	0.000
N88.3 Incompetence of cervix uteri	0.007	0.993	0.000
N88.0 Leukoplakia of cervix uteri	0.007	0.993	0.000
N80.3 Endometriosis of pelvic peritoneum	0.007	0.993	0.000
N80.2 Endometriosis of Fallopian tube	0.007	0.993	0.000
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.006	0.994	0.000
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.006	0.994	0.000
H02 Other disorders of eyelid	0.000	0.994	0.006
N91.2 Amenorrhoea, unspecified	0.006	0.994	0.000
N85.9 Noninflammatory disorder of uterus, unspecified	0.006	0.994	0.000
N92.1 Excessive and frequent menstruation with irregular cycle	0.006	0.994	0.000
N92.2 Excessive menstruation at puberty	0.006	0.994	0.000
N84 Polyp of female genital tract	0.006	0.994	0.000
N91.5 Oligomenorrhoea, unspecified	0.005	0.994	0.000
N91.4 Secondary oligomenorrhoea	0.005	0.994	0.000
N91.3 Primary oligomenorrhoea	0.005	0.994	0.000
N91.1 Secondary amenorrhoea	0.005	0.994	0.000
N91.0 Primary amenorrhoea	0.005	0.994	0.000
N82.3 Fistula of vagina to large intestine	0.005	0.994	0.000
N83.1 Corpus luteum cyst	0.005	0.994	0.000
N82.9 Female genital tract fistula, unspecified	0.005	0.995	0.000
N82.8 Other female genital tract fistulae	0.005	0.995	0.000
N82.5 Female genital tract-skin fistulae	0.005	0.995	0.000
N82.4 Other female intestinal-genital tract fistulae	0.005	0.995	0.000
N82.2 Fistula of vagina to small intestine	0.005	0.995	0.000
N82.1 Other female urinary-genital tract fistulae	0.005	0.995	0.000
N82.0 Vesicovaginal fistula	0.005	0.995	0.000
A04.9 Bacterial intestinal infection, unspecified	0.000	0.995	0.005
A04.6 Enteritis due to Yersinia enterocolitica	0.000	0.995	0.005
A04.4 Other intestinal Escherichia coli infections	0.000	0.995	0.005
A04.3 Enterohaemorrhagic Escherichia coli infection	0.000	0.995	0.005
A04.2 Enteroinvasive Escherichia coli infection	0.000	0.995	0.005
A04.1 Enterotoxigenic Escherichia coli infection	0.000	0.995	0.005
A04.0 Enteropathogenic Escherichia coli infection	0.000	0.995	0.005
N98.9 Complication associated with artificial fertilisation, unspecified	0.005	0.995	0.000
N98.8 Other complications associated with artificial fertilisation	0.005	0.995	0.000
N98.3 Complications of attempted introduction of embryo in embryo transfer	0.005	0.995	0.000
N98.2 Complications of attempted introduction of fertilised ovum following in vitro fertilisation	0.005	0.995	0.000
N98.1 Hyperstimulation of ovaries	0.005	0.995	0.000
N98.0 Infection associated with artificial insemination	0.005	0.995	0.000
N87 Dysplasia of cervix uteri	0.005	0.995	0.000
N83.5 Torsion of ovary, ovarian pedicle and Fallopian tube	0.005	0.995	0.000
H02.5 Other disorders affecting eyelid function	0.000	0.995	0.005
C18.7 Sigmoid colon	0.005	0.995	0.000
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.005	0.995	0.000
H02.3 Blepharochalasis	0.000	0.995	0.005
N92.5 Other specified irregular menstruation	0.005	0.995	0.000
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified	0.005	0.995	0.000
N83.7 Haematoma of broad ligament	0.005	0.995	0.000
N83.6 Haematosalpinx	0.005	0.995	0.000
N83.4 Prolapse and hernia of ovary and Fallopian tube	0.005	0.995	0.000
H02.0 Entropion and trichiasis of eyelid	0.000	0.995	0.005
N83.3 Acquired atrophy of ovary and Fallopian tube	0.005	0.995	0.000
N83.0 Follicular cyst of ovary	0.005	0.995	0.000
C54.1 Endometrium	0.005	0.995	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.005	0.995	0.000
Y40 Systemic antibiotics	0.005	0.995	0.000
N85.2 Hypertrophy of uterus	0.005	0.995	0.000
H02.7 Other degenerative disorders of eyelid and periocular area	0.000	0.995	0.004
H02.2 Lagophthalmos	0.000	0.995	0.004
N87.2 Severe cervical dysplasia, not elsewhere classified	0.004	0.996	0.000
N92.3 Ovulation bleeding	0.004	0.996	0.000
A04.5 Campylobacter enteritis	0.000	0.996	0.004
Y40.0 Penicillins	0.004	0.996	0.000
H02.1 Ectropion of eyelid	0.000	0.996	0.004
N84.9 Polyp of female genital tract, unspecified	0.004	0.996	0.000
N84.8 Polyp of other parts of female genital tract	0.004	0.996	0.000
N84.3 Polyp of vulva	0.004	0.996	0.000
N84.0 Polyp of corpus uteri	0.004	0.996	0.000
N88.2 Stricture and stenosis of cervix uteri	0.004	0.996	0.000
N84.1 Polyp of cervix uteri	0.004	0.996	0.000
Y40.8 Other systemic antibiotics	0.004	0.996	0.000
N87.9 Dysplasia of cervix uteri, unspecified	0.004	0.996	0.000
N94 Pain and other conditions associated with female genital organs and menstrual cycle	0.004	0.996	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.004	0.996	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
R07.4 Chest pain, unspecified	0.000	0.996	0.004
I77.1 Stricture of artery	0.004	0.996	0.000
N92.0 Excessive and frequent menstruation with regular cycle	0.004	0.996	0.000
H02.6 Xanthelasma of eyelid	0.000	0.996	0.003
Y53.1 Other antacids and anti-gastric-secretion drugs	0.004	0.996	0.000
Y40.7 Antifungal antibiotics, systemically used	0.003	0.996	0.000
Y40.6 Rifamycins	0.003	0.996	0.000
Y40.5 Aminoglycosides	0.003	0.996	0.000
Y40.4 Tetracyclines	0.003	0.996	0.000
Y40.3 Macrolides	0.003	0.996	0.000
Y40.2 Chloramphenicol group	0.003	0.996	0.000
H91.9 Hearing loss, unspecified	0.004	0.996	0.000
Y52 Agents primarily affecting the cardiovascular system	0.003	0.996	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.000	0.997	0.003
Y51 Drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
N87.0 Mild cervical dysplasia	0.003	0.997	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
N84.2 Polyp of vagina	0.003	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
Y53.4 Other laxatives	0.003	0.997	0.000
N94.5 Secondary dysmenorrhoea	0.003	0.997	0.000
T81.2 Accidental puncture and laceration during a procedure, not elsewhere classified	0.000	0.997	0.003
Y40.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
Y57 Other and unspecified drugs and medicaments	0.003	0.997	0.000
C78.7 Secondary malignant neoplasm of liver	0.000	0.997	0.003
N94.4 Primary dysmenorrhoea	0.003	0.997	0.000
N94.2 Vaginismus	0.003	0.997	0.000
N94.0 Mittelschmerz	0.003	0.997	0.000
N85.4 Malposition of uterus	0.003	0.997	0.000
K90-K93 Other diseases of the digestive system	0.003	0.997	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
Y52.1 Calcium-channel blockers	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
Y58 Bacterial vaccines	0.003	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.997	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.003	0.997	0.000
M54.46 Lumbago with sciatica (Lumbar region)	0.003	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y53.7 Emetics	0.003	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.003	0.997	0.000
Y53.5 Digestants	0.003	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.003	0.997	0.000
Y53.2 Stimulant laxatives	0.003	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.003	0.997	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.003	0.997	0.000
N94.9 Unspecified condition associated with female genital organs and menstrual cycle	0.003	0.997	0.000
Y48 Anaesthetics and therapeutic gases	0.003	0.997	0.000
Y41.0 Sulphonamides	0.003	0.997	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
N90 Other noninflammatory disorders of vulva and perineum	0.003	0.997	0.000
Y42.7 Androgens and anabolic congeners	0.003	0.997	0.000
G31.2 Degeneration of nervous system due to alcohol	0.003	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
K90 Intestinal malabsorption	0.003	0.997	0.000
H02.9 Disorder of eyelid, unspecified	0.000	0.997	0.003
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
Y57.9 Drug or medicament, unspecified	0.003	0.997	0.000
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
G31.9 Degenerative disease of nervous system, unspecified	0.003	0.997	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
Y51.0 Anticholinesterase agents	0.003	0.997	0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.003	0.997	0.000
H91 Other hearing loss	0.003	0.997	0.000
Y43 Primarily systemic agents	0.003	0.997	0.000
N87.1 Moderate cervical dysplasia	0.003	0.997	0.000
O26.8 Other specified pregnancy-related conditions	0.003	0.997	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Y42.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
Y42.4 Oral contraceptives	0.003	0.997	0.000
Y42.2 Antithyroid drugs	0.003	0.997	0.000
Y42.1 Thyroid hormones and substitutes	0.003	0.997	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.997	0.000
Y41.5 Antiviral drugs	0.002	0.997	0.000
Y41.4 Anthelminthics	0.002	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.997	0.000
Y41.1 Antimycobacterial drugs	0.002	0.997	0.000
C54 Malignant neoplasm of corpus uteri	0.003	0.997	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
N90.4 Leukoplakia of vulva	0.003	0.997	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.003	0.997	0.000
N94.8 Other specified conditions associated with female genital organs and menstrual cycle	0.003	0.997	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.997	0.000
G31.0 Circumscribed brain atrophy	0.002	0.997	0.000
N94.3 Premenstrual tension syndrome	0.002	0.997	0.000
Y57.8 Other drugs and medicaments	0.002	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.002	0.997	0.000
Y57.6 Other diagnostic agents	0.002	0.997	0.000
Y57.4 Pharmaceutical excipients	0.002	0.997	0.000
Y57.3 Alcohol deterrents	0.002	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.997	0.000
Y57.1 Lipotropic drugs	0.002	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.997	0.000
H02.8 Other specified disorders of eyelid	0.000	0.997	0.002
K90.0 Coeliac disease	0.002	0.997	0.000
N90.3 Dysplasia of vulva, unspecified	0.002	0.998	0.000
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.002	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
K93 Disorders of other digestive organs in diseases classified elsewhere	0.002	0.998	0.000
G31.8 Other specified degenerative diseases of nervous system	0.002	0.998	0.000
N94.6 Dysmenorrhoea, unspecified	0.002	0.998	0.000
K90.9 Intestinal malabsorption, unspecified	0.002	0.998	0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.000	0.998	0.002
N80.9 Endometriosis, unspecified	0.002	0.998	0.001
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.998	0.000
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
N94.1 Dyspareunia	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
N90.2 Severe vulvar dysplasia, not elsewhere classified	0.002	0.998	0.000
N90.1 Moderate vulvar dysplasia	0.002	0.998	0.000
N90.0 Mild vulvar dysplasia	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
Y54.5 Other diuretics	0.002	0.998	0.000
K90.8 Other intestinal malabsorption	0.002	0.998	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.002	0.998	0.000
K90.3 Pancreatic steatorrhoea	0.002	0.998	0.000
K90.2 Blind loop syndrome, not elsewhere classified	0.002	0.998	0.000
K90.1 Tropical sprue	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
K14.9 Disease of tongue, unspecified	0.000	0.998	0.002
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
G31.1 Senile degeneration of brain, not elsewhere classified	0.002	0.998	0.000
H91.8 Other specified hearing loss	0.002	0.998	0.000
H91.3 Deaf mutism, not elsewhere classified	0.002	0.998	0.000
H91.2 Sudden idiopathic hearing loss	0.002	0.998	0.000
H91.1 Presbycusis	0.002	0.998	0.000
H91.0 Ototoxic hearing loss	0.002	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.002	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.998	0.000
Y43.2 Antineoplastic natural products	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
Y43.4 Immunosuppressive agents	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
K14.8 Other diseases of tongue	0.000	0.998	0.002
Y45.1 Salicylates	0.002	0.998	0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.000	0.998	0.002
C54.9 Corpus uteri, unspecified	0.002	0.998	0.000
C54.8 Overlapping lesion of corpus uteri	0.002	0.998	0.000
C54.3 Fundus uteri	0.002	0.998	0.000
C54.2 Myometrium	0.002	0.998	0.000
C54.0 Isthmus uteri	0.002	0.998	0.000
D30.3 Bladder	0.002	0.998	0.000
Y43.3 Other antineoplastic drugs	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
Y45.8 Other analgesics and antipyretics	0.002	0.998	0.000
Y45.5 4-Aminophenol derivatives	0.002	0.998	0.000
Y45.4 Antirheumatics	0.002	0.998	0.000
K50.9 Crohn's disease, unspecified	0.000	0.998	0.002
C18.9 Colon, unspecified	0.002	0.998	0.000
I65.2 Occlusion and stenosis of carotid artery	0.002	0.998	0.000
Y45.2 Propionic acid derivatives	0.002	0.998	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
H90-H95 Other disorders of ear	0.002	0.998	0.000
S92.00 Fracture of calcaneus (closed)	0.002	0.998	0.000
S92.20 Fracture of other tarsal bone(s) (closed)	0.002	0.998	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.000	0.998	0.002
R10.2 Pelvic and perineal pain	0.002	0.998	0.000
Y45.0 Opioids and related analgesics	0.002	0.998	0.000
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere	0.002	0.998	0.000
K93.1 Megacolon in Chagas' disease	0.002	0.998	0.000
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands	0.002	0.998	0.000
L91.8 Other hypertrophic disorders of skin	0.002	0.998	0.000
S92.4 Fracture of great toe	0.002	0.998	0.000
S92.0 Fracture of calcaneus	0.002	0.998	0.000
S92.2 Fracture of other tarsal bone(s)	0.002	0.998	0.000
S92 Fracture of foot, except ankle	0.002	0.998	0.000
H33.0 Retinal detachment with retinal break	0.002	0.998	0.000
N90.7 Vulvar cyst	0.002	0.998	0.000
J13 Pneumonia due to Streptococcus pneumoniae	0.002	0.998	0.000
D10.1 Tongue	0.002	0.998	0.000
H73.8 Other specified disorders of tympanic membrane	0.002	0.998	0.000
H93 Other disorders of ear, not elsewhere classified	0.002	0.998	0.000
S92.40 Fracture of great toe (closed)	0.002	0.998	0.000
Y44.2 Anticoagulants	0.002	0.998	0.000
N90.6 Hypertrophy of vulva	0.002	0.998	0.000
S92.41 Fracture of great toe (open)	0.002	0.998	0.000
I26.9 Pulmonary embolism without mention of acute cor pulmonale	0.002	0.998	0.000
I42.0 Dilated cardiomyopathy	0.002	0.998	0.000
Y43.1 Antineoplastic antimetabolites	0.002	0.998	0.000
N95 Menopausal and other perimenopausal disorders	0.002	0.998	0.000
C18.6 Descending colon	0.002	0.998	0.000
S92.7 Multiple fractures of foot	0.002	0.998	0.000
C78.1 Secondary malignant neoplasm of mediastinum	0.000	0.998	0.002
H90.2 Conductive hearing loss, unspecified	0.002	0.998	0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.001	0.998	0.001
M54.4 Lumbago with sciatica	0.002	0.998	0.000
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified	0.002	0.998	0.000
M54.47 Lumbago with sciatica (Lumbosacral region)	0.002	0.998	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.000	0.998	0.002
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.000	0.998	0.002
N04.9 Unspecified	0.000	0.998	0.002
S92.5 Fracture of other toe	0.002	0.998	0.000
Z86.0 Personal history of other neoplasms	0.000	0.998	0.002
S92.70 Multiple fractures of foot (closed)	0.002	0.998	0.000
D30.0 Kidney	0.002	0.998	0.000
D30 Benign neoplasm of urinary organs	0.002	0.998	0.000
H94 Other disorders of ear in diseases classified elsewhere	0.002	0.998	0.000
H90 Conductive and sensorineural hearing loss	0.002	0.998	0.000
H93.9 Disorder of ear, unspecified	0.002	0.998	0.000
S92.1 Fracture of talus	0.002	0.998	0.000
J30.1 Allergic rhinitis due to pollen	0.000	0.998	0.002
H93.1 Tinnitus	0.002	0.998	0.000
Y42.5 Other oestrogens and progestogens	0.002	0.998	0.000
H73 Other disorders of tympanic membrane	0.002	0.998	0.000
S92.01 Fracture of calcaneus (open)	0.002	0.998	0.000
S92.21 Fracture of other tarsal bone(s) (open)	0.002	0.998	0.000
N90.5 Atrophy of vulva	0.002	0.998	0.000
S92.9 Fracture of foot, unspecified	0.002	0.998	0.000
S92.50 Fracture of other toe (closed)	0.002	0.998	0.000
H92 Otalgia and effusion of ear	0.002	0.998	0.000
K14 Diseases of tongue	0.000	0.998	0.002
N93 Other abnormal uterine and vaginal bleeding	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations